论文信息 - CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain. - 字舞流文

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.

J. Masferrer | M. Graneto | G. Anderson | L. Cortes-Burgos | B. Zweifel | R. A. Pufahl | M. Hardy | S. Settle | F. Happa | D. E. Weir | George Hu | Zachary S Stewart | S. Muthian | Zachary S. Stewart